MedTrace Logo

Intranasal Dexmedetomidine in Children Undergoing Adenotonsillectomy Suffering From Mild Upper Respiratory Tract Infection

NCT05639777 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-12-07

No results posted yet for this study

Summary

The purpose of this study is to detect the efficacy of intranasal dexmedetomidine as a premedication to general anesthesia in pediatric patients with respiratory comorbidities undergoing adenotonsillectomy.

Conditions

  • Dexmedetomidine
  • Adenotonsillectomy
  • Respiratory Tract Infections

Interventions

DRUG

Dexmedetomidine group

That will receive intranasal dexmedetomidine (1.5mcg/kg)

OTHER

control group

That will receive the same volume of 2 ml of intranasal normal saline

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Ayman A Yousef, Professor · Anesthiology' Surgical Intensive care and Pain Medicine

  • Gehan M Eid, Professor · Assistant Professor Anesthiology' Surgical Intensive care and Pain Medicine

  • Wail E Messbah, Lecturer · Anesthiology' Surgical Intensive care and Pain Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-06
Primary Completion
2023-05-15
Completion
2023-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05639777 on ClinicalTrials.gov